PARAMETERS OF THYMIDYLATE SYNTHETASE (TS) INHIBITION IN BLADDER-CARCINOMA AFTER INTRAVESICAL 5-FLUOROURACIL (5-FU) COMBINED WITH SYSTEMIC ALLOPURINOL PROTECTION

被引：0

作者：

SPEARS, CP

GUSTAVSSON, B

LEISSNER, KH

DANENBERG, PV

机构：

[1] UNIV SO CALIF,CTR COMPREHENS CANC,LOS ANGELES,CA 90033

[2] GOTHENBURG UNIV,OSTRA HOSP,DEPT SURG,S-41124 GOTHENBURG,SWEDEN

来源：

PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1984年 / 25卷 / MAR期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：166 / 166

页数：1

共 42 条

[21] 5-DAY IV INFUSION WITH 5-FLUOROURACIL (5-FU-NSC-19893) FOR GASTROENTERIC CARCINOMA AFTER FAILURE ON WEEKLY 5-FU THERAPY
HUM, GJ
BATEMAN, JR
CANCER CHEMOTHERAPY REPORTS PART 1, 1975, 59 (06): : 1177 - 1179
[22] CONTROLLED EVALUATION OF HIGH DOSE RADIATION AND COMBINED RADIATION AND 5-FLUOROURACIL (5-FU) THERAPY FOR LOCALLY UNRESECTABLE PANCREATIC CARCINOMA
KALSER, MH
GASTROENTEROLOGY, 1977, 72 (05) : 1077 - 1077
[23] INTRAVESICAL HIGH-DOSE 5-FLUOROURACIL INSTILLATIONS COMBINED WITH ALLOPURINOL - A THERAPEUTIC ALTERNATIVE IN THE TREATMENT OF MULTIPLE BLADDER-TUMORS
LEISSNER, KH
GUSTAVSSON, B
JOURNAL OF UROLOGY, 1984, 132 (01): : 34 - 36
[24] Rapid and complete thymidylate synthase (TS) inhibition in tumors after fluorouracil (5-FU) by methylene-tetrahydrofolate (ch2fh4) preloading
Spears, CP
Gustavsson, B
Carlsson, G
Odin, E
EUROPEAN JOURNAL OF CANCER, 2002, 38 : S22 - S22
[25] Absorption and distribution characteristics of 5-fluorouracil (5-FU) after an application to the liver surface in rats in order to reduce systemic side effects
Kodama, Yukinobu
Fumoto, Shintaro
Nishi, Junya
Nakashima, Mikiro
Sasaki, Hitoshi
Nakamura, Junzo
Nishida, Koyo
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008, 31 (05) : 1049 - 1052
[26] Expression of thymidylate synthase (TS) and p53 in primary colorectal adenocarcinomas and their relationship to response to protracted venous infusional (PVI) 5-fluorouracil (5-FU) chemotherapy.
Wong, NACS
Brett, L
Stewart, M
Johnston, PG
Lessells, AM
Jodrell, DI
JOURNAL OF PATHOLOGY, 1999, 189 : 1A - 1A
[27] A RANDOMIZED STUDY IN METASTATIC COLORECTAL-CARCINOMA (MCRC) COMPARING SYSTEMIC 5 FLUOROURACIL (5-FU) ALONE VERSUS 5-FU COMBINED WITH PLASMA PERFUSION OVER PROTEIN-A-SEPHAROSE (PASPP)
FARADJI, A
DAMONTE, JC
ARNAUD, JP
OLLIER, JC
BERGERAT, JP
LANG, JM
ADLOFF, M
OBERLING, F
INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 71 - 71
[28] RANDOMIZED PHASE-II STUDY OF A COMBINATION OF CISPLATIN (DDP), 5-FLUOROURACIL (5-FU), AND ALLOPURINOL (HPP) VERSUS 5-FU IN ADVANCED COLORECTAL-CARCINOMA - AN EORTC GASTROINTESTINAL-TRACT CANCER COOPERATIVE GROUP-STUDY
BLEIBERG, H
VANDERLINDEN, B
BUYSE, M
HAEGELE, P
PAILLOT, B
TAGNON, A
WILS, J
CARTEI, G
FORNASIERO, A
DUEZ, N
CANCER INVESTIGATION, 1990, 8 (05) : 471 - 475
[29] HIGH-DOSE FOLINIC ACID (FA) COMBINED WITH 5-FLUOROURACIL (5-FU) FOR TREATMENT OF ADVANCED-CARCINOMA (CA) - INVESTIGATION OF EFFICACY AND TOXICITY
CUNNINGHAM, JR
BUKOWSKI, RM
HEWLETT, JS
WEICK, JK
CLINICAL RESEARCH, 1982, 30 (04): : A746 - A746
[30] Thymidylate synthase (TS) and p53 protein expression in patients with rectal cancer treated with pre-operative 5-fluorouracil (5-FU) based chemo-radiotherapy (CRT).
Ward, SA
Joel, SP
Papamichael, D
Slevin, ML
Glynne-Jones, R
BRITISH JOURNAL OF CANCER, 1998, 78 : 30 - 30

← 1 2 3 4 5 →